I would not allow my pt to into a double blind stu

Quote:

---

I would not allow my pt to into a double blind study of a drug already proven to decrease mortality if was available another way I could guarantee they get the drug

---

I understand what you're saying and it makes perfect sense, and it's a legitimate concern. My only question with this, and I don't know the answer, is how many critical patients are there (< 65) that are currently on ventilators? The reason I ask is I would imagine there are thousands within the U.S., so I can't see all of these patients getting accepted under an EIND due to the volume. Perhaps it would be faster to enroll them in the new trial even though there's a chance they may only get the SOC.

Just a thought...

My comments are just my opinions and should NOT be taken as investment advice.